Kezar Life Net Worth
Kezar Life Net Worth Breakdown | KZR |
Kezar Life Net Worth Analysis
Kezar Life's net worth analysis, or its valuation, is the process of determining the total value of the company. This involves assessing a range of factors, including Kezar Life's financial performance, assets, liabilities, and potential for growth. The ultimate goal is to provide a clear understanding of Kezar Life's overall worth, which can help investors make informed investment decisions. There are several methods that can be used to perform Kezar Life's net worth analysis. One common approach is to calculate Kezar Life's market capitalization.Another approach is to use the price-to-earnings ratio (P/E ratio), which compares Kezar Life's stock price to its earnings per share (EPS). Discounted cash flow (DCF) analysis is another popular method for assessing Kezar Life's net worth. This approach calculates the present value of Kezar Life's future cash flows, taking into account factors such as growth rate, profitability, and risk. By comparing the present value of Kezar Life's cash flows to its current stock price, investors can gain a better understanding of the company's overall value. Finally, investors may use comparable company analysis to evaluate Kezar Life's net worth. This involves comparing Kezar Life's financial metrics to similar companies in the same industry. By identifying companies with similar financial characteristics, investors can gain insight into Kezar Life's net worth relative to its peers.
To determine if Kezar Life is a good investment, evaluating the company's potential for future growth is also very important. This may include expanding into new markets, launching new products or services, or improving operational efficiency. Companies with strong growth prospects can be more attractive investments. This aspect of the research should be conducted in the context of the overall market and industry in which the company operates and should include an analysis of growth potential, competitive landscape, and any regulatory or economic factors that could impact the business. Some of the essential points regarding Kezar Life's net worth research are outlined below:
| Kezar Life Sciences generated a negative expected return over the last 90 days | |
| Kezar Life Sciences has high likelihood to experience some financial distress in the next 2 years | |
| The company reported the last year's revenue of 7 M. Reported Net Loss for the year was (101.87 M) with loss before taxes, overhead, and interest of (72.35 M). | |
| Kezar Life Sciences has about 306.84 M in cash with (81.64 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 4.49. | |
| Kezar Life Sciences has a frail financial position based on the latest SEC disclosures | |
| Roughly 62.0% of the company shares are owned by institutional investors | |
| Latest headline from MacroaxisInsider: Acquisition by Garner Elizabeth of 26000 shares of Kezar Life at 2.28 subject to Rule 16b-3 |
Kezar Life uses earnings reports to provide investors with an update of all three financial statements, including the income statement, the balance sheet, and the cash flow statement. Therefore, it is also crucial when considering investing in Kezar Life Sciences. Every quarterly earnings report provides investors with an overview of sales, expenses, and net income for the most recent period. It also may provide a comparison to Kezar Life's previous reporting period. The quarterly earnings reports are usually disseminated to the public via Form 10-Q, which is a legal document filed with the Securities and Exchange Commission every quarter.
| 12th of March 2024 Upcoming Quarterly Report | View | |
| 9th of May 2024 Next Financial Report | View | |
| 31st of December 2023 Next Fiscal Quarter End | View | |
| 12th of March 2024 Next Fiscal Year End | View | |
| 30th of September 2023 Last Quarter Report | View | |
| 31st of December 2022 Last Financial Announcement | View |
Kezar Life Target Price Consensus
Kezar target price is determined by taking all analyst projections and averaging them out. There is no one specific way to measure analysts' performance other than comparing it to past results via a very sophisticated attribution analysis. Kezar Life's target price projections below should be used in combination with other traditional price prediction techniques such as stock price forecasting, investor sentiment analysis, technical analysis, earnings estimate, and various momentum models.
| 6 | Buy |
Most Kezar analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to help potential investors understand Kezar stock's fair price compared to its market value. Analysts arrive at stock ratings after researching the public financial statements of Kezar Life Sciences, talking to its executives and customers, or listening to those companies' conference calls.
Macroaxis Advice Exposure ValuationKezar Life Target Price Projection
Kezar Life's current and average target prices are 5.76 and 13.50, respectively. The current price of Kezar Life is the price at which Kezar Life Sciences is currently trading. On the other hand, Kezar Life's target price is what analysts think the stock is worth or could sell for in the future. The more significant the discrepancy between the two prices, the more it stimulates investors to act.Target Price
Analyst Consensus On Kezar Life Target Price
Know Kezar Life's Top Institutional Investors
Have you ever been surprised when a price of an equity instrument such as Kezar Life is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Kezar Life Sciences backward and forwards among themselves. Kezar Life's institutional investor refers to the entity that pools money to purchase Kezar Life's securities or originate loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
| Shares | |||
| Two Sigma Advisers, Llc | 2024-12-31 | 100.1 K | |
| Renaissance Technologies Corp | 2024-12-31 | 87.7 K | |
| Qiming U.s. Ventures Management, Llc | 2024-12-31 | 82.9 K | |
| Blackrock Inc | 2024-12-31 | 82.9 K | |
| Geode Capital Management, Llc | 2024-12-31 | 66.6 K | |
| Two Sigma Investments Llc | 2024-12-31 | 62 K | |
| Shay Capital Llc | 2024-12-31 | 59.2 K | |
| Goldman Sachs Group Inc | 2024-12-31 | 52.3 K | |
| Bml Capital Management Llc | 2024-12-31 | 48.7 K | |
| Tang Capital Management Llc | 2024-12-31 | 720 K | |
| Suvretta Capital Management, Llc | 2024-12-31 | 716.8 K |
Follow Kezar Life's market capitalization trends
The company currently falls under 'Micro-Cap' category with a total capitalization of 44.51 M.Market Cap |
|
Project Kezar Life's profitablity
| Last Reported | Projected for Next Year | ||
| Return On Tangible Assets | (0.41) | (0.44) | |
| Return On Capital Employed | (0.47) | (0.49) | |
| Return On Assets | (0.41) | (0.44) | |
| Return On Equity | (0.62) | (0.59) |
When accessing Kezar Life's net worth, it's important to look at multiple sources and consider different scenarios. For example, gross profit margin measures Kezar Life's profitability after accounting for the cost of goods sold, while net profit margin measures profitability after accounting for all expenses. Other important metrics include return on assets, return on equity, and free cash flow. By reviewing multiple sources and metrics, you can gain a complete picture of Kezar Life's profitability and make more informed investment decisions.
Evaluate Kezar Life's management efficiency
Kezar Life Sciences has Return on Asset of (0.2902) % which means that on every $100 spent on assets, it lost $0.2902. This is way below average. In the same way, it shows a return on shareholders' equity (ROE) of (0.5472) %, meaning that it generated no profit with money invested by stockholders. Kezar Life's management efficiency ratios could be used to measure how well Kezar Life manages its routine affairs as well as how well it operates its assets and liabilities. As of 03/10/2025, Return On Tangible Assets is likely to drop to -0.44. In addition to that, Return On Capital Employed is likely to drop to -0.49. At this time, Kezar Life's Net Tangible Assets are relatively stable compared to the past year. As of 03/10/2025, Non Current Assets Total is likely to grow to about 17.2 M, while Other Current Assets are likely to drop slightly above 3.4 M.| Last Reported | Projected for Next Year | ||
| Book Value Per Share | 2.33 | 2.49 | |
| Tangible Book Value Per Share | 2.33 | 2.49 | |
| Enterprise Value Over EBITDA | (62.15) | (65.26) | |
| Price Book Value Ratio | 32.97 | 34.62 | |
| Enterprise Value Multiple | (62.15) | (65.26) | |
| Price Fair Value | 32.97 | 34.62 | |
| Enterprise Value | 6.2 B | 5.5 B |
Evaluating the management effectiveness of Kezar Life allows investors to assess its financial health and operational efficiency. Coupled with an analysis of its growth prospects and the current market dynamics, we evaluate the stock's true value and future potential. Key indicators such as revenue, earnings or debt levels are examined alongside external factors like economic trends and regulatory changes. The Kezar Stock analysis seeks to determine whether the stock is undervalued, appropriately priced, or overvalued, thereby guiding your investment decisions.
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Kezar Life insiders, such as employees or executives, is commonly permitted as long as it does not rely on Kezar Life's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Kezar Life insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Kezar Life Corporate Filings
| 6th of March 2025 Other Reports | ViewVerify | |
F4 | 5th of March 2025 The report filed by a party regarding the acquisition or disposition of a company's common stock, as well as derivative securities such as options, warrants, and convertible securities | ViewVerify |
| 3rd of March 2025 Other Reports | ViewVerify | |
8K | 27th of February 2025 Report filed with the SEC to announce major events that shareholders should know about | ViewVerify |
Kezar Life Earnings Estimation Breakdown
The calculation of Kezar Life's earning per share is based on the data from the past 12 consecutive months, used for reporting the company's financial figures. The next projected EPS of Kezar Life is estimated to be -1.675 with the future projection ranging from a low of -2.8225 to a high of -0.5275. Please be aware that this consensus of annual earnings estimates for Kezar Life Sciences is based on EPS before non-recurring items and includes expenses related to employee stock options.Last Reported EPS
-2.82 Lowest | Expected EPS | -0.53 Highest |
Kezar Life Earnings Projection Consensus
Suppose the current estimates of Kezar Life's value are higher than the current market price of the Kezar Life stock. In this case, investors may conclude that Kezar Life is overpriced and will exhibit bullish sentiment. On the other hand, if the present value is lower than the stock price, analysts may conclude that the market undervalues the equity. These scenarios may suggest that the market is not as efficient as it should be at the estimation time, and Kezar Life's stock will quickly adjusts to the new information provided by the consensus estimate.
| Number of Analysts | Historical Accuracy | Last Reported EPS | Estimated EPS for 31st of December 2024 | Current EPS (TTM) | |
| 6 | 88.21% | -2.78 | -1.675 | -13.12 |
Kezar Life Earnings per Share Projection vs Actual
Actual Earning per Share of Kezar Life refers to what the company shows during its earnings calls or quarterly reports. The Expected EPS is what analysts covering Kezar Life Sciences predict the company's earnings will be in the future. The higher the earnings per share of Kezar Life, the better is its profitability. While calculating the Earning per Share, we use the weighted ratio, as the number of shares outstanding can change over time.Kezar Life Estimated Months Earnings per Share
For an investor who is primarily interested in generating an income out of investing in entities such as Kezar Life, the EPS ratio can tell if the company is intending to increase its current dividend. Although EPS is an essential tool for investors, it should not be used in isolation. EPS of Kezar Life should always be considered in relation to other companies to make a more educated investment decision.Kezar Quarterly Analyst Estimates and Surprise Metrics
Earnings surprises can significantly impact Kezar Life's stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate.
| Reported | Fiscal Date | Estimated EPS | Reported EPS | Surprise | |||
|---|---|---|---|---|---|---|---|
2024-11-13 | 2024-09-30 | -3.15 | -2.78 | 0.37 | 11 | ||
2024-08-13 | 2024-06-30 | -0.32 | -0.27 | 0.05 | 15 | ||
2024-05-09 | 2024-03-31 | -0.33 | -0.3 | 0.03 | 9 | ||
2024-03-14 | 2023-12-31 | -0.38 | -0.44 | -0.06 | 15 | ||
2023-11-13 | 2023-09-30 | -0.35 | -0.32 | 0.03 | 8 | ||
2023-08-10 | 2023-06-30 | -0.32 | -0.34 | -0.02 | 6 | ||
2023-05-11 | 2023-03-31 | -0.29 | -0.31 | -0.02 | 6 | ||
2023-03-14 | 2022-12-31 | -0.28 | -0.25 | 0.03 | 10 | ||
2022-11-10 | 2022-09-30 | -0.27 | -0.25 | 0.02 | 7 | ||
2022-08-11 | 2022-06-30 | -0.27 | -0.25 | 0.02 | 7 | ||
2022-05-12 | 2022-03-31 | -0.28 | -0.26 | 0.02 | 7 | ||
2022-03-17 | 2021-12-31 | -0.3 | -0.25 | 0.05 | 16 | ||
2021-11-09 | 2021-09-30 | -0.26 | -0.28 | -0.02 | 7 | ||
2021-08-12 | 2021-06-30 | -0.26 | -0.25 | 0.01 | 3 | ||
2021-05-12 | 2021-03-31 | -0.24 | -0.25 | -0.01 | 4 | ||
2021-03-11 | 2020-12-31 | -0.23 | -0.22 | 0.01 | 4 | ||
2020-11-05 | 2020-09-30 | -0.21 | -0.23 | -0.02 | 9 | ||
2020-08-05 | 2020-06-30 | -0.26 | -0.22 | 0.04 | 15 | ||
2020-05-07 | 2020-03-31 | -0.37 | -0.3 | 0.07 | 18 | ||
2020-03-12 | 2019-12-31 | -0.54 | -0.5 | 0.04 | 7 | ||
2019-11-06 | 2019-09-30 | -0.51 | -0.48 | 0.03 | 5 | ||
2019-08-07 | 2019-06-30 | -0.48 | -0.46 | 0.02 | 4 | ||
2019-05-07 | 2019-03-31 | -0.4 | -0.4 | 0.0 | 0 | ||
2019-03-26 | 2018-12-31 | -0.44 | -0.3 | 0.14 | 31 | ||
2018-11-08 | 2018-09-30 | -0.48 | -0.3 | 0.18 | 37 | ||
2018-08-09 | 2018-06-30 | -0.52 | -3.31 | -2.79 | 536 | ||
2018-05-24 | 2018-03-31 | 0 | -4.67 | -4.67 | 0 | ||
2018-03-21 | 2017-12-31 | 0 | 0.02 | 0.02 | 0 |
Kezar Life Corporate Management
| Joe Tedrick | Vice Resources | Profile | |
| Noreen MD | Chief Officer | Profile | |
| Pattie Chiang | Senior Controller | Profile | |
| Michael Wolfe | Sr Operations | Profile |
Additional Tools for Kezar Stock Analysis
When running Kezar Life's price analysis, check to measure Kezar Life's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Kezar Life is operating at the current time. Most of Kezar Life's value examination focuses on studying past and present price action to predict the probability of Kezar Life's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Kezar Life's price. Additionally, you may evaluate how the addition of Kezar Life to your portfolios can decrease your overall portfolio volatility.